Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 11—November 2005
Perspective

Emergence of Toscana Virus in Europe

Rémi N. Charrel*Comments to Author , Pierre Gallian*†, José-María Navarro-Marí‡, Loredana Nicoletti§, Anna Papa¶, Mária Paz Sánchez-Seco#, Antonio Tenorio#, and Xavier de Lamballerie*
Author affiliations: *Université de la Méditerranée, Marseille, France; †Etablissement Français du Sang Alpes-Méditerranée, Marseille, France; ‡Hospital Universitario Virgen de la Nieves, Granada, Spain; §Istituto Superiore di Sanita, Rome, Italy; ¶Aristotle University of Thessaloniki, Thessaloniki, Greece; #Instituto de Salud Carlos III, Madrid, Spain

Main Article

Figure 1

Provinces of Italy and Spain in which clinical cases of Toscana virus (TOSV) infection have been documented, and seroprevalence studies were conducted. PCR, polymerase chain reaction; IgM, immunoglobulin M.

Figure 1. Provinces of Italy and Spain in which clinical cases of Toscana virus (TOSV) infection have been documented, and seroprevalence studies were conducted. PCR, polymerase chain reaction; IgM, immunoglobulin M.

Main Article

Page created: February 17, 2012
Page updated: February 17, 2012
Page reviewed: February 17, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external